Comparing Rates of Polycythemia in Hypogonadal Men Using Nasal Testosterone Gel Versus Intramuscular Testosterone: Update of a Randomized Clinical Trial

Eur Urol Focus. 2023 Jan;9(1):14-16. doi: 10.1016/j.euf.2022.09.001. Epub 2022 Sep 13.

¹ Department of Urology, Dalhousie University, Halifax, NS, Canada. Electronic address: jesse.ory@dal.ca.
² Department of Urology, Miller School of Medicine, University of Miami, Miami, Florida.
³ Department of Urology, University of California-Davis, Sacramento, CA, USA.
⁴ Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
⁵ Department of Urology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USA.
⁶ Department of Urology, NYU Langone Health, New York, NY, USA.

Abstract

Men with hypogonadism who use intranasal testosterone are less likely to develop polycythemia than men using intramuscular testosterone cypionate.